Douglas Thomson active positions
| Companies | Position | Start | End |
|---|---|---|---|
AvantiCell Science Ltd.
 AvantiCell Science Ltd. Pharmaceuticals: MajorHealth Technology AvantiCell Science Ltd. develops cell-based assays for use in drug discovery, materials testing and biomedical research. Its products include cryotix, human primary cells, human cell lines, animal primary cells, cell based assays and liquid medium. It also provides stander analysis, analytical readouts, population based analysis and natural product testing services. The company was founded by Joanna Jane Oliver and Colin James Wilde in 2006 and is headquartered in Ayr, the United Kingdom. | Chairman | - | - |
Pneumagen Ltd.
 Pneumagen Ltd. BiotechnologyHealth Technology Pneumagen Ltd. is engaged in biotechnology services. The company was founded in 2016 and is headquartered in Fife, the United Kingdom. | Chief Executive Officer | - | - |
Career history of Douglas Thomson
Former positions of Douglas Thomson
| Companies | Position | Start | End |
|---|---|---|---|
MGB Biopharma Ltd.
 MGB Biopharma Ltd. BiotechnologyHealth Technology MGB Biopharma Ltd. develops anti-infective medicines. Its lead candidate, MGB-BP-3, is an antibacterial which is active against important multi-resistant and susceptible Gram-positive pathogens. The firm develops an oral formulation of MGB-BP-3 for the treatment of clostridium difficile associated disease. The company was founded by Miroslav Ravic, Gavin David Clark and Raymond Spencer in 2010 and is headquartered in Glasgow, the United Kingdom. | Director/Board Member | - | - |
Statistics
International
| United Kingdom | 4 |
Operational
| Director/Board Member | 1 |
| Chairman | 1 |
| Chief Executive Officer | 1 |
Sectoral
| Health Technology | 4 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 3 |
|---|---|
MGB Biopharma Ltd.
MGB Biopharma Ltd. BiotechnologyHealth Technology MGB Biopharma Ltd. develops anti-infective medicines. Its lead candidate, MGB-BP-3, is an antibacterial which is active against important multi-resistant and susceptible Gram-positive pathogens. The firm develops an oral formulation of MGB-BP-3 for the treatment of clostridium difficile associated disease. The company was founded by Miroslav Ravic, Gavin David Clark and Raymond Spencer in 2010 and is headquartered in Glasgow, the United Kingdom. | Health Technology |
AvantiCell Science Ltd.
AvantiCell Science Ltd. Pharmaceuticals: MajorHealth Technology AvantiCell Science Ltd. develops cell-based assays for use in drug discovery, materials testing and biomedical research. Its products include cryotix, human primary cells, human cell lines, animal primary cells, cell based assays and liquid medium. It also provides stander analysis, analytical readouts, population based analysis and natural product testing services. The company was founded by Joanna Jane Oliver and Colin James Wilde in 2006 and is headquartered in Ayr, the United Kingdom. | Health Technology |
Pneumagen Ltd.
Pneumagen Ltd. BiotechnologyHealth Technology Pneumagen Ltd. is engaged in biotechnology services. The company was founded in 2016 and is headquartered in Fife, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Douglas Thomson
- Experience
